Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024
Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focusing on innovative treatments for obesity and type 2 diabetes, has announced it will release its second quarter 2024 financial results and provide business updates on August 14, 2024, at 4:30 p.m. ET. The company will host a live webcast of the conference call, which can be accessed through the 'Events' section of Fractyl's investor relations website. For those unable to attend the live event, an archived version of the webcast will be made available for replay on the company's website.
Fractyl Health (Nasdaq: GUTS), un'azienda di terapie metaboliche che si concentra su trattamenti innovativi per l'obesità e il diabete di tipo 2, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 e fornirà aggiornamenti sull'attività il 14 agosto 2024, alle 16:30 ET. L'azienda ospiterà un webcast dal vivo della conference call, accessibile attraverso la sezione 'Eventi' del sito web delle relazioni con gli investitori di Fractyl. Per coloro che non possono partecipare all'evento dal vivo, sarà disponibile una versione archiviatata del webcast per la visione successiva sul sito dell'azienda.
Fractyl Health (Nasdaq: GUTS), una empresa de terapias metabólicas enfocada en tratamientos innovadores para la obesidad y la diabetes tipo 2, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 y ofrecerá actualizaciones comerciales el 14 de agosto de 2024, a las 4:30 p.m. ET. La empresa llevará a cabo un webcast en vivo de la llamada de conferencia, que se podrá acceder a través de la sección 'Eventos' del sitio web de relaciones con inversionistas de Fractyl. Para aquellos que no puedan asistir al evento en vivo, se disponibilizará una versión archivada del webcast para su reproducción en el sitio web de la empresa.
Fractyl Health (Nasdaq: GUTS)는 비만 및 제2형 당뇨병을 위한 혁신적인 치료에 중점을 둔 대사 치료 회사로, 2024년 2분기 재무 결과를 발표하고 비즈니스 업데이트를 제공할 것이라고 발표했습니다. 발표는 2024년 8월 14일 오후 4:30 ET에 진행됩니다. 회사는 Fractyl의 투자자 관계 웹사이트의 '이벤트' 섹션을 통해 액세스할 수 있는 실시간 웹캐스트를 개최합니다. 실시간 이벤트에 참석할 수 없는 분들을 위해, 회사 웹사이트에 기록된 웹캐스트 버전이 나중에 재생할 수 있도록 제공됩니다.
Fractyl Health (Nasdaq: GUTS), une société de thérapies métaboliques axée sur des traitements innovants pour l'obésité et le diabète de type 2, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 et fournira des mises à jour commerciales le 14 août 2024, à 16h30 HE. L'entreprise organisera un webinaire en direct de la conférence téléphonique, accessible via la section 'Événements' du site web des relations investisseurs de Fractyl. Pour ceux qui ne peuvent pas assister à l'événement en direct, une version archivée du webinaire sera disponible pour relecture sur le site de l'entreprise.
Fractyl Health (Nasdaq: GUTS), ein Unternehmen für metabolische Therapien, das sich auf innovative Behandlungen von Fettleibigkeit und Typ-2-Diabetes konzentriert, hat angekündigt, dass es am 14. August 2024 um 16:30 Uhr ET seine Finanzergebnisse für das zweite Quartal 2024 veröffentlichen und Unternehmensupdates bereitstellen wird. Das Unternehmen wird ein Live-Webcast zur Telefonkonferenz veranstalten, der über den Abschnitt 'Veranstaltungen' auf der Investor-Relations-Website von Fractyl zugänglich ist. Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird eine archivierte Version des Webcasts zur späteren Ansicht auf der Website des Unternehmens verfügbar sein.
- None.
- None.
BURLINGTON, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it will report financial results for the second quarter 2024 and provide business updates on Wednesday, August 14, 2024, at 4:30 p.m. ET.
A live webcast of the conference call can be accessed in the “Events” section of Fractyl’s website at https://ir.fractyl.com/. The webcast will be archived and available for replay following the live event.
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit www.fractyl.com or www.twitter.com/FractylHealth.
Contacts
Corporate Contact
Lisa Davidson, Chief Financial Officer
ir@fractyl.com, 781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com, 978.760.5622
Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com, 619.949.3681
FAQ
When will Fractyl Health (GUTS) report its Q2 2024 financial results?
How can I access Fractyl Health's (GUTS) Q2 2024 earnings call?
What is Fractyl Health's (GUTS) primary focus as a company?
Will there be a replay available for Fractyl Health's (GUTS) Q2 2024 earnings call?
